@inproceedings{remak_changes_2002-1,
	address = {Rotterdam, The Netherlands},
	title = {Changes in cost-effectiveness over time – {The} case of {Epoetin} alfa for renal replacement therapy patients in the {UK}},
	publisher = {Value in Health},
	author = {Remák, E. and Hutton, J. and Zagari, M.},
	month = nov,
	year = {2002},
}

{"_id":"Tzc4e86pQfRN9dirM","bibbaseid":"remk-hutton-zagari-changesincosteffectivenessovertimethecaseofepoetinalfaforrenalreplacementtherapypatientsintheuk-2002","author_short":["Remák, E.","Hutton, J.","Zagari, M."],"bibdata":{"bibtype":"inproceedings","type":"inproceedings","address":"Rotterdam, The Netherlands","title":"Changes in cost-effectiveness over time – The case of Epoetin alfa for renal replacement therapy patients in the UK","publisher":"Value in Health","author":[{"propositions":[],"lastnames":["Remák"],"firstnames":["E."],"suffixes":[]},{"propositions":[],"lastnames":["Hutton"],"firstnames":["J."],"suffixes":[]},{"propositions":[],"lastnames":["Zagari"],"firstnames":["M."],"suffixes":[]}],"month":"November","year":"2002","bibtex":"@inproceedings{remak_changes_2002-1,\n\taddress = {Rotterdam, The Netherlands},\n\ttitle = {Changes in cost-effectiveness over time – {The} case of {Epoetin} alfa for renal replacement therapy patients in the {UK}},\n\tpublisher = {Value in Health},\n\tauthor = {Remák, E. and Hutton, J. and Zagari, M.},\n\tmonth = nov,\n\tyear = {2002},\n}\n\n","author_short":["Remák, E.","Hutton, J.","Zagari, M."],"bibbaseid":"remk-hutton-zagari-changesincosteffectivenessovertimethecaseofepoetinalfaforrenalreplacementtherapypatientsintheuk-2002","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"inproceedings","biburl":"https://bibbase.org/f/FfNE7kWA6pCvwcJZF/myPubs.bib","dataSources":["ZaHtWavQhcwZqKLNF","iRRNaRs6FkffgErta","zeMwFvgpdRkYAkfoD","v8uQmZsBpiqycmskv"],"keywords":[],"search_terms":["changes","cost","effectiveness","over","time","case","epoetin","alfa","renal","replacement","therapy","patients","remák","hutton","zagari"],"title":"Changes in cost-effectiveness over time – The case of Epoetin alfa for renal replacement therapy patients in the UK","year":2002}